-
1دورية أكاديمية
المؤلفون: Beckermann, Kathryn E., Patnaik, Amita, Winer, Ira, Tan, Winston, Bashir, Babar, Kyriakopoulos, Christos E., Sweis, Randy F., Chamberlain, Marc, Rini, Brian I.Aff1, IDs10637024014191_cor9
المصدر: Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 42(2):179-184
-
2دورية أكاديمية
المؤلفون: Ji Son, Rodney Cheng-En Hsieh, Heather Y. Lin, Kate J. Krause, Ying Yuan, Amadeo B. Biter, James Welsh, Michael A. Curran, David S. Hong
المصدر: Frontiers in Immunology, Vol 13 (2022)
مصطلحات موضوعية: CD47 inhibitor, SIRPα inhibitor, next generation checkpoint inhibition, checkpoint inhibitor resistance, clinical trial, novel therapeutics, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Victor Cervera-Carrascon, Dafne C. A. Quixabeira, Joao M. Santos, Riikka Havunen, Ioanna Milenova, Jan Verhoeff, Camilla Heiniö, Sadia Zafar, Juan J. Garcia-Vallejo, Victor W. van Beusechem, Tanja D. de Gruijl, Aino Kalervo, Suvi Sorsa, Anna Kanerva, Akseli Hemminki
المصدر: Frontiers in Immunology, Vol 12 (2021)
مصطلحات موضوعية: cancer immunotherapy, oncolytic virus, adenovirus, checkpoint inhibitor resistance, tumor microenvironment, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
5كتاب إلكتروني
المؤلفون: DeVito, N.Aff4, Morse, M. A.Aff4, Hanks, B.Aff4, Clarke, J. M.Aff4
المساهمون: El-Deiry, Wafik, Series editorAff1, Patel, Sandip Pravin, editorAff2, Kurzrock, Razelle, editorAff3
المصدر: Early Phase Cancer Immunotherapy. :219-241
-
6
المؤلفون: Lövgren, Tanja, Wolodarski, Maria, Wickstrom, Stina, Edback, Ulrika, Wallin, Mette, Martell, Eva, Markland, Katrin, Blomberg, Pontus, Nystrom, Maria, Lundqvist, Andreas, Jacobsson, Hans, Ullenhag, Gustav, Ljungman, Per, Hansson, Johan, Masucci, Giuseppe, Tell, Roger, Poschke, Isabel, Adamson, Lars, Mattsson, Jonas, Kiessling, Rolf
المصدر: Oncoimmunology. 9(1)
مصطلحات موضوعية: Combination immunotherapy, adoptive tumor-infiltrating lymphocyte therapy, tumor lysate, DC vaccination, immune checkpoint inhibitor resistance
وصف الملف: electronic
URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-419059
https://doi.org/10.1080/2162402X.2020.1792058
https://uu.diva-portal.org/smash/get/diva2:1469150/FULLTEXT01.pdf -
7دورية أكاديمية
المؤلفون: Jacob J. Orme, Khalid A. Jazieh, Tiancheng Xie, Susan Harrington, Xin Liu, Matthew Ball, Benjamin Madden, M. Cristine Charlesworth, Tariq U. Azam, Fabrice Lucien, Bharath Wootla, Yanli Li, Jose Caetano Villasboas, Aaron S. Mansfield, Roxana S. Dronca, Haidong Dong
المصدر: OncoImmunology, Vol 9, Iss 1 (2020)
مصطلحات موضوعية: pd-1 resistance, checkpoint inhibitor resistance, spd-l1, adam10, adam17, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2162-402X
-
8دورية أكاديمية
المؤلفون: Tanja Lövgren, Maria Wolodarski, Stina Wickström, Ulrika Edbäck, Mette Wallin, Eva Martell, Katrin Markland, Pontus Blomberg, Maria Nyström, Andreas Lundqvist, Hans Jacobsson, Gustav Ullenhag, Per Ljungman, Johan Hansson, Giuseppe Masucci, Roger Tell, Isabel Poschke, Lars Adamson, Jonas Mattsson, Rolf Kiessling
المصدر: OncoImmunology, Vol 9, Iss 1 (2020)
مصطلحات موضوعية: combination immunotherapy, adoptive tumor-infiltrating lymphocyte therapy, tumor lysate, dc vaccination, immune checkpoint inhibitor resistance, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2162-402X
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: Cervera-Carrascon, Victor, Quixabeira, Dafne C.A., Santos, Joao M., Havunen, Riikka, Milenova, Ioanna, Verhoeff, Jan, Heiniö, Camilla, Zafar, Sadia, Garcia-Vallejo, Juan J., van Beusechem, Victor W., de Gruijl, Tanja D., Kalervo, Aino, Sorsa, Suvi, Kanerva, Anna, Hemminki, Akseli
المساهمون: Medical oncology laboratory, Molecular cell biology and Immunology, AII - Cancer immunology, CCA - Cancer biology and immunology, Department of Pathology, TRIMM - Translational Immunology Research Program, Faculty of Medicine, Research Programs Unit, Medicum, HUS Comprehensive Cancer Center, Genome-Scale Biology (GSB) Research Program, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Clinicum, Department of Obstetrics and Gynecology, Department of Oncology
المصدر: Frontiers in Immunology
Frontiers in Immunology, 12:706517. Frontiers Media S.A.
Cervera-Carrascon, V, Quixabeira, D C A, Santos, J M, Havunen, R, Milenova, I, Verhoeff, J, Heiniö, C, Zafar, S, Garcia-Vallejo, J J, van Beusechem, V W, de Gruijl, T D, Kalervo, A, Sorsa, S, Kanerva, A & Hemminki, A 2021, ' Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1 ', Frontiers in Immunology, vol. 12, 706517 . https://doi.org/10.3389/fimmu.2021.706517مصطلحات موضوعية: checkpoint inhibitor resistance, Immunology, Programmed Cell Death 1 Receptor, Melanoma, Experimental, T-CELL THERAPY, Adenoviridae, Mice, IMPROVES, Immunology and Allergy, tumor microenvironment, Animals, COMBINATION, Immune Checkpoint Inhibitors, Original Research, oncolytic virus, Oncolytic Virotherapy, cancer immunotherapy, LANDSCAPE, Tumor Necrosis Factor-alpha, NECROSIS-FACTOR-ALPHA, ONCOLYTIC VIRUSES, adenovirus, PD-1 BLOCKADE, Mice, Inbred C57BL, Drug Resistance, Neoplasm, Interleukin-2, Female, 3111 Biomedicine, ACQUIRED-RESISTANCE
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::298f437b1efacbc8618ea2fb364658b5
http://europepmc.org/articles/PMC8343222
Find this article in full text from Springer Verlag. 
Full Text Finder 
PDF full text from Publisher